Global Moles Treatment Market, By Origin Type (Congenital Nevi and Acquired Moles), Location Type (Junctional Melanocytic Nevi and Intradermal Nevi), Treatment Type (Medication and Surgery), Route of Administration (Injectable and Topical), End-Users (Clinic, Hospital, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2031.
Moles Treatment Market Analysis and Size
The moles treatment market is experiencing significant growth driven by advancements in technology and methods. The latest techniques offer more precise and effective treatments, enhancing patient outcomes and satisfaction. This evolution is expanding the market's scope as demand increases for safer, less invasive procedures. Innovations continue to reshape the landscape, promising continued expansion and improved accessibility in mole treatment options.
The global moles treatment market size was valued at USD 176.02 million in 2023, is projected to reach USD 349.70 million by 2031, with a CAGR of 8.96% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Origin Type (Congenital Nevi and Acquired Moles), Location Type (Junctional Melanocytic Nevi and Intradermal Nevi), Treatment Type (Medication and Surgery), Route of Administration (Injectable and Topical), End-Users (Clinic, Hospital, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Bausch Health Companies Inc. (Canada), Medtronic (U.S.), Stryker (U.S.), Boston Scientific Corporation (U.S.), Novartis AG (Switzerland), Perrigo Company plc (Ireland), Sun Pharmaceutical Industries Ltd. (India), Apotex Inc (Canada), and Glenmark Pharmaceuticals Limited (India)
|
|
Market Opportunities
|
|
Market Definition
Moles can be treated through various methods depending on their type and location. Options include surgical removal, laser therapy, and cryotherapy (freezing). Surgical excision involves cutting out the mole and stitching the wound. Laser treatment for moles uses focused light to break down pigments in the mole. Cryotherapy freezes the mole using liquid nitrogen. Consulting a dermatologist ensures the best treatment approach for each case.
Global Moles Treatment Market Dynamics
Drivers
- Rising Incidence of Skin Disorders
The rising incidence of skin disorders, such as an increase in abnormal moles, significantly drives the moles treatment market. For instance, the American Academy of Dermatology reported a notable rise in skin cancer cases linked to abnormal moles. This surge in skin conditions necessitates more treatment options, thereby boosting market demand for advanced mole removal techniques and dermatological care.
- Advancements in Dermatology
Technological advancements in dermatology, such as laser therapy and cryotherapy, have significantly enhanced the effectiveness and accessibility of mole removal treatment procedures. For instance, modern laser treatments can precisely target and remove moles with minimal scarring and downtime. These innovations make treatments more appealing and widely available, driving the market as patients seek efficient, less invasive options for mole removal.
Opportunities
- Growing Medical Tourism
Increased medical tourism significantly boosts the moles treatment market by attracting patients seeking cost-effective and high-quality dermatological care. For instance, countries such as India and Thailand offer advanced mole removal procedures at a fraction of the cost compared to Western nations. This affordability, combined with state-of-the-art facilities and skilled dermatologists, drives more international patients to these regions, thereby expanding the market for mole treatments.
- Expansion of Dermatology Clinics and Spas
The proliferation of specialized dermatology clinics and medical spas offering mole treatment services significantly enhances market accessibility and growth. For instance, the opening of new dermatology centers equipped with advanced mole removal technologies in urban areas has made these treatments more readily available to a broader population. This expansion not only meets the rising demand for aesthetic and medical mole treatments but also drives the overall market growth through increased service availability.
Restraints/Challenges
- Scarcity of Data
The scarcity of long-term data on the outcomes and safety of newer mole treatment methods can significantly hinder the market. Without comprehensive, longitudinal studies, both patients and healthcare providers may lack confidence in the efficacy and safety of innovative treatments. This uncertainty can lead to hesitation in adopting new technologies, limiting market growth and the widespread implementation of potentially more effective or advanced treatment options.
- Limited Access to Specialists
Limited access to dermatologists and specialists in certain regions hinders the moles treatment market by affecting the availability of timely and effective care. This geographical disparity restricts patients' ability to receive advanced treatments, leading to potential delays in diagnosis and management. Consequently, the market faces challenges in expanding its reach and ensuring consistent treatment standards, ultimately impacting overall market growth and patient outcomes.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Moles Treatment Market Scope
The market is segmented on the basis of origin type, location type, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Origin Type
- Congenital Nevi
- Acquired Moles
Location Type
- Junctional Melanocytic Nevi
- Intradermal Nevi
Treatment Type
- Medication
- Imiquimod Cream
- Surgery
- Surgical Excision
- Surgical Shave
- Radio Surgery
Route of Administration
- Injectable
- Topical
End-Users
- Clinic
- Hospital
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Moles Treatment Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, origin type, location type, treatment type, route of administration, end-users and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to grow in the moles treatment market during the forecast period, driven by increasing research and development activities, rising investment in the healthcare sector, and growing government support. These factors aim to enhance treatment options and accessibility across the region.
North America is expected to dominate the moles treatment market due to the presence of major key players, high disposable income, significant healthcare expenditure, and a well-developed healthcare sector. These factors collectively contribute to the region's leadership in providing advanced and accessible mole treatment options.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Moles Treatment Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Bausch Health Companies Inc. (Canada)
- Medtronic (U.S.)
- Stryker (U.S.)
- Boston Scientific Corporation (U.S.)
- Novartis AG (Switzerland)
- Perrigo Company plc (Ireland)
- Sun Pharmaceutical Industries Ltd. (India)
- Apotex Inc (Canada)
- Glenmark Pharmaceuticals Limited (India)
SKU-